Paolo Fornara
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Paolo Fornara has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
- Francesco Greco
Urology Unit, Centro Salute Uomo, Bergamo, Italy
7 shared publications - Amir Hamza
Department of Biochemistry, Hallym University College of Medicine, Chuncheon, Kangwon-do 24252, Republic of Korea., Republic of Korea
4 shared publications - M. Raschid Hoda
Department of Urology, University Hospital Schleswig-Holstein, Campus Lübeck, 23538 Lübeck, Germany
4 shared publications Antonino Inferrera
Department of Urology and Kidney Transplantation, Martin-Luther-University, Halle, Saale, Germany
3 shared publicationsFelix Kawan
Department of Urology and Kidney Transplantation, Martin-Luther-University, Halle, Saale, Germany
3 shared publications- Gerit Theil
Medical Faculty of Martin Luther University Halle-Wittenberg, University Clinic and Outpatient Clinic for Urology, 06120 Halle (Saale), Germany
3 shared publications
Latest Publications
- 6 November 2023
- Published by Elsevier in Progrès en Urologie - FMC
- Vol. 33 (3) , S22
Transplantation rénale robot-assistée avec donneur vivant : résultats actualisés d’une série multicentrique européenne (ERUS-RAKT)
- 6 November 2023
- Published by Elsevier in Progrès en Urologie - FMC
- Vol. 33 (3) , S22
Transplantation rénale robot-assistée avec donneur vivant : résultats actualisés d’une série multicentrique européenne (ERUS-RAKT)
- Open Access
- 1 July 2022
- Published by AVES YAYINCILIK A.Ş. in Urology Research and Practice
- Vol. 48 (4) , 303-308
Does the Inverted Kidney Transplantation Technique Promote the Feasibility and Safety of Right Living Donor Nephrectomy?
Objective: The aim of this study is to compare the outcomes of right- and left-sided live donor nephrectomies using the inverted kidney transplantation technique for right live donor nephrectomy on transplantation. Material and methods: A retrospective review was done for the cases of live donor nephrectomy, either as open donor nephrectomy or laparoscopic donor nephrectomy between 2004 and 2019. Inverted kidney transplantation was used with right-sided grafts. The variables of the right- and left-sided live donor nephrectomies were compared. Results: There were 202 live donor nephrectomies including 71 (35.1%) open donor nephrectomies and 131 (64.9%) laparoscopic donor nephrectomies with 4 cases of conversion to open donor nephrectomy. There were 119 (58.9%) right-sided and 83 (41.1%) left-sided live donor nephrectomies with insignificantly different mean operative time (123 and 127 minutes; P=.09), mean warm ischemia time (82.3 and 84.5 seconds; P=.32), and mean blood loss (73 and 78 mL; P=.18), respectively. Inverted kidney transplantation was performed for 86% of grafts from right live donor nephrectomies. Discharge from hospital was on an average of 4.3 days postoperatively. There were only 3 complications (1 in right live donor nephrectomy and 2 in left live donor nephrectomies) with grade 2 according to Clavien–Dindo Classification. Incidence of delayed graft function (P=.09), transplant vein thrombosis (1 case in each group), 1-year graft survival rate (93.2% vs. 94.8%; P=.12), and 1-year serum creatinine levels (1.4 ± 0.3 vs. 1.3 ± 0.2; P=.09) revealed statistically insignificant differences. Conclusion: Regardless of the surgical technique, the right live donor nephrectomy seems to be technically as safe as the left live donor nephrectomy for both the donors and the recipients. Using inverted kidney transplantation provided convenient extensions of graft’s vessels to full length with no significant increased incidence of vascular thrombosis Cite this article as: Mohammed N, Zarzour MA, Abdelgawad AM, Ibrahim HM, Fornara P, Gadelkareem RA. Does the inverted kidney transplantation technique promote the feasibility and safety of right living donor nephrectomy? Turk J Urol. 2022;48(4):303-308.
- 1 July 2022
- Published by AVES YAYINCILIK A.Ş. in Urology Research and Practice
- Vol. 48 (4) , 303-308
Open AccessDoes the Inverted Kidney Transplantation Technique Promote the Feasibility and Safety of Right Living Donor Nephrectomy?
Objective: The aim of this study is to compare the outcomes of right- and left-sided live donor nephrectomies using the inverted kidney transplantation technique for right live donor nephrectomy on transplantation. Material and methods: A retrospective review was done for the cases of live donor nephrectomy, either as open donor nephrectomy or laparoscopic donor nephrectomy between 2004 and 2019. Inverted kidney transplantation was used with right-sided grafts. The variables of the right- and left-sided live donor nephrectomies were compared. Results: There were 202 live donor nephrectomies including 71 (35.1%) open donor nephrectomies and 131 (64.9%) laparoscopic donor nephrectomies with 4 cases of conversion to open donor nephrectomy. There were 119 (58.9%) right-sided and 83 (41.1%) left-sided live donor nephrectomies with insignificantly different mean operative time (123 and 127 minutes; P=.09), mean warm ischemia time (82.3 and 84.5 seconds; P=.32), and mean blood loss (73 and 78 mL; P=.18), respectively. Inverted kidney transplantation was performed for 86% of grafts from right live donor nephrectomies. Discharge from hospital was on an average of 4.3 days postoperatively. There were only 3 complications (1 in right live donor nephrectomy and 2 in left live donor nephrectomies) with grade 2 according to Clavien–Dindo Classification. Incidence of delayed graft function (P=.09), transplant vein thrombosis (1 case in each group), 1-year graft survival rate (93.2% vs. 94.8%; P=.12), and 1-year serum creatinine levels (1.4 ± 0.3 vs. 1.3 ± 0.2; P=.09) revealed statistically insignificant differences. Conclusion: Regardless of the surgical technique, the right live donor nephrectomy seems to be technically as safe as the left live donor nephrectomy for both the donors and the recipients. Using inverted kidney transplantation provided convenient extensions of graft’s vessels to full length with no significant increased incidence of vascular thrombosis Cite this article as: Mohammed N, Zarzour MA, Abdelgawad AM, Ibrahim HM, Fornara P, Gadelkareem RA. Does the inverted kidney transplantation technique promote the feasibility and safety of right living donor nephrectomy? Turk J Urol. 2022;48(4):303-308.
- 1 June 2021
- Published by Elsevier in European Urology
- Vol. 79, S1363
Dreaming of gender equity in urology: An analysis of urological congresses
- 1 June 2021
- Published by Elsevier in European Urology
- Vol. 79, S1363
Dreaming of gender equity in urology: An analysis of urological congresses
- Open Access
- 1 October 2018
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 10, 4173-4180
Expression of GP88 (progranulin) in serum of prostate cancer patients is associated with Gleason scores and overall survival
Background: GP88/Progranulin is a well-recognized cell growth promoter in different cancers, and elevated serum GP88 levels have been described as negative prognostic factor in breast cancer. However, serum levels in prostate cancer (PCa) patients have not yet been studied. Material and Methods: We analyzed serum GP88 levels by enzyme immunosorbent assay and correlated them with clinicopathological parameters in PCa patients. PCa patients were separated into two groups based on the serum GP88 median level (low ≤44.56 ng/mL or high >44.56 ng/mL) and according to their median age (younger ≤66 years or elder patients >66 years). Results: Low serum GP88 levels were more often detected in younger patients and high levels in elder patients (P=0.018; Fisher’s exact test). PCa patients were separated into three groups, Gleason score (GS) ≤6; GS=7; and GS≥8. In receiver operating characteristic analyses, we could distinguish GS≤6 from GS=7 [area under the curve (AUC): 0.646; P=0.018] and GS≤6 from GS≥8 (AUC: 0.629; P=0.048) but not GS=7 from GS≥8. For survival analysis, GP88 levels were separated into two groups by an optimized cutoff value of 36.92 ng/mL. Using this GP88 stratification, all PCa patients and younger patients with a low serum GP88 level had a significantly better overall survival compared with patients with higher serum GP88 levels (log-rank test P=0.010 and P=0.024). Conclusion: Serum GP88 levels are significantly different depending on age and GS, and they are associated with the prognosis of PCa patients.
- 1 October 2018
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 10, 4173-4180
Open AccessExpression of GP88 (progranulin) in serum of prostate cancer patients is associated with Gleason scores and overall survival
Background: GP88/Progranulin is a well-recognized cell growth promoter in different cancers, and elevated serum GP88 levels have been described as negative prognostic factor in breast cancer. However, serum levels in prostate cancer (PCa) patients have not yet been studied. Material and Methods: We analyzed serum GP88 levels by enzyme immunosorbent assay and correlated them with clinicopathological parameters in PCa patients. PCa patients were separated into two groups based on the serum GP88 median level (low ≤44.56 ng/mL or high >44.56 ng/mL) and according to their median age (younger ≤66 years or elder patients >66 years). Results: Low serum GP88 levels were more often detected in younger patients and high levels in elder patients (P=0.018; Fisher’s exact test). PCa patients were separated into three groups, Gleason score (GS) ≤6; GS=7; and GS≥8. In receiver operating characteristic analyses, we could distinguish GS≤6 from GS=7 [area under the curve (AUC): 0.646; P=0.018] and GS≤6 from GS≥8 (AUC: 0.629; P=0.048) but not GS=7 from GS≥8. For survival analysis, GP88 levels were separated into two groups by an optimized cutoff value of 36.92 ng/mL. Using this GP88 stratification, all PCa patients and younger patients with a low serum GP88 level had a significantly better overall survival compared with patients with higher serum GP88 levels (log-rank test P=0.010 and P=0.024). Conclusion: Serum GP88 levels are significantly different depending on age and GS, and they are associated with the prognosis of PCa patients.
- 3 July 2018
- Published by Springer Nature in Der Urologe
- Vol. 57 (9) , 1069-1074
Innovation in der individualisierten Medizin
- 3 July 2018
- Published by Springer Nature in Der Urologe
- Vol. 57 (9) , 1069-1074
Innovation in der individualisierten Medizin
- 1 April 2014
- Published by Elsevier in European Urology Supplements
- Vol. 13 (1) , e207
207 The isolation of prostate cancer specific circulating tumor cells in the blood of patients with metastatic castration-resistant prostate cancer
- 1 April 2014
- Published by Elsevier in European Urology Supplements
- Vol. 13 (1) , e207
207 The isolation of prostate cancer specific circulating tumor cells in the blood of patients with metastatic castration-resistant prostate cancer
- 1 March 2013
- Published by Elsevier in European Urology Supplements
- Vol. 12 (1) , eV1-eV2
V1 Clampless laparoendoscopic single-site partial nephrectomy for renal cancer with low PADUA score: Technique and surgical outcomes
- 1 March 2013
- Published by Elsevier in European Urology Supplements
- Vol. 12 (1) , eV1-eV2
V1 Clampless laparoendoscopic single-site partial nephrectomy for renal cancer with low PADUA score: Technique and surgical outcomes
- 1 March 2013
- Published by Elsevier in European Urology Supplements
- Vol. 12 (1) , e1046-e1047
1046 A new medical device for in vivo isolation of circulating tumor cells in prostate cancer patients
- 1 March 2013
- Published by Elsevier in European Urology Supplements
- Vol. 12 (1) , e1046-e1047
1046 A new medical device for in vivo isolation of circulating tumor cells in prostate cancer patients
- 16 December 2012
- Published by Springer Nature in World Journal of Urology
- Vol. 31 (1) , 213-218
Laparoendoscopic single-site versus conventional laparoscopic radical nephrectomy for renal cell cancer in patients with increased comorbidities and previous abdominal surgery: preliminary results of a single-centre retrospective study
Objective Laparoendoscopic single-site surgery (LESS) represents an evolution of laparoscopy for the treatment for urologic diseases. The aim of this study is to investigate the feasibility of LESS in patients with increased comorbidities and previous abdominal surgery undergoing radical nephrectomy (LESS-RN) for renal cell carcinoma. Materials and methods A total of 25 patients with increased comorbidities and previous abdominal surgery who underwent LESS-RN were compared to 31 patients with the same characteristics after conventional laparoscopic radical nephrectomy (LRN). LRN was performed between January 2009 and May 2010, and LESS-RNs were performed between June 2010 and November 2011. Demographic data and perioperative and postoperative variables were recorded and analysed. Results The mean ASA score in the LESS-RN and LRN groups was 3.2 ± 0.4, and the mean BMI was 32.7 ± 2.1 and 34.2 ± 0.8 kg/m2, respectively. The mean operative time in the LESS-RN and LRN groups was 143.7 ± 24.3 and 130.6 ± 26.5 min, (p = 0.11), and the mean hospital stay was 3.8 ± 0.8 versus 4.2 ± 1.4 days in the two groups (p = 0.06), respectively. Three and four complications were recorded in the LESS-RN and in the LRN groups, for a mean complication rate of 12 and 12.9 % (p = 0.12), respectively All tumours were organ-confined with negative surgical margins, and the mean R.E.N.A.L nephrometry score for LESS-RN and LRN was 9.78 ± 1.7 and 9.82 ± 1.3 (p = 0.14), respectively. Conclusions LESS-RN in patients with increased comorbidities and previous abdominal surgery is equally effective as LRN without compromising on surgical, oncologic short-term and postoperative outcomes.
- 16 December 2012
- Published by Springer Nature in World Journal of Urology
- Vol. 31 (1) , 213-218
Laparoendoscopic single-site versus conventional laparoscopic radical nephrectomy for renal cell cancer in patients with increased comorbidities and previous abdominal surgery: preliminary results of a single-centre retrospective study
Objective Laparoendoscopic single-site surgery (LESS) represents an evolution of laparoscopy for the treatment for urologic diseases. The aim of this study is to investigate the feasibility of LESS in patients with increased comorbidities and previous abdominal surgery undergoing radical nephrectomy (LESS-RN) for renal cell carcinoma. Materials and methods A total of 25 patients with increased comorbidities and previous abdominal surgery who underwent LESS-RN were compared to 31 patients with the same characteristics after conventional laparoscopic radical nephrectomy (LRN). LRN was performed between January 2009 and May 2010, and LESS-RNs were performed between June 2010 and November 2011. Demographic data and perioperative and postoperative variables were recorded and analysed. Results The mean ASA score in the LESS-RN and LRN groups was 3.2 ± 0.4, and the mean BMI was 32.7 ± 2.1 and 34.2 ± 0.8 kg/m2, respectively. The mean operative time in the LESS-RN and LRN groups was 143.7 ± 24.3 and 130.6 ± 26.5 min, (p = 0.11), and the mean hospital stay was 3.8 ± 0.8 versus 4.2 ± 1.4 days in the two groups (p = 0.06), respectively. Three and four complications were recorded in the LESS-RN and in the LRN groups, for a mean complication rate of 12 and 12.9 % (p = 0.12), respectively All tumours were organ-confined with negative surgical margins, and the mean R.E.N.A.L nephrometry score for LESS-RN and LRN was 9.78 ± 1.7 and 9.82 ± 1.3 (p = 0.14), respectively. Conclusions LESS-RN in patients with increased comorbidities and previous abdominal surgery is equally effective as LRN without compromising on surgical, oncologic short-term and postoperative outcomes.
- 1 October 2012
- Published by Elsevier in European Urology Supplements
- Vol. 11 (4) , 126
C183 LAPAROSCOPIC VS OPEN BILATERAL INTRAFASCIAL NERVE-SPARING RADICAL PROSTATECTOMY AFTER TUR-P FOR INCIDENTAL PROSTATE CANCER: SURGICAL OUTCOMES AND EFFECT ON THE POSTOPERATIVE URINARY CONTINENCE AND SEXUAL POTENCY
- 1 October 2012
- Published by Elsevier in European Urology Supplements
- Vol. 11 (4) , 126
C183 LAPAROSCOPIC VS OPEN BILATERAL INTRAFASCIAL NERVE-SPARING RADICAL PROSTATECTOMY AFTER TUR-P FOR INCIDENTAL PROSTATE CANCER: SURGICAL OUTCOMES AND EFFECT ON THE POSTOPERATIVE URINARY CONTINENCE AND SEXUAL POTENCY